BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25450387)

  • 1. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
    Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
    Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells.
    Magnus N; Garnier D; Rak J
    Blood; 2010 Aug; 116(5):815-8. PubMed ID: 20462964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model.
    Harter PN; Dützmann S; Drott U; Zachskorn C; Hattingen E; Capper D; Gessler F; Senft C; Seifert V; Plate KH; Kögel D; Mittelbronn M
    Neuropathology; 2013 Oct; 33(5):515-25. PubMed ID: 23384223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
    Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
    Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.
    Milsom CC; Yu JL; Mackman N; Micallef J; Anderson GM; Guha A; Rak JW
    Cancer Res; 2008 Dec; 68(24):10068-76. PubMed ID: 19074872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1.
    Yu JL; Xing R; Milsom C; Rak J
    Thromb Res; 2010 Jul; 126(1):e6-10. PubMed ID: 20553947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
    Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
    Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
    Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
    Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tissue factor correlates with grade of malignancy in human glioma.
    Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
    Cancer; 1996 May; 77(9):1877-83. PubMed ID: 8646688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain neoplasms and coagulation.
    Magnus N; D'Asti E; Garnier D; Meehan B; Rak J
    Semin Thromb Hemost; 2013 Nov; 39(8):881-95. PubMed ID: 24108471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
    Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
    Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy.
    D'Asti E; Rak J
    Thromb Res; 2016 Apr; 140 Suppl 1():S37-43. PubMed ID: 27067976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
    Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
    Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
    Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS
    Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.